Obesity, SDB, T2DM
Conditions
Brief summary
SDB has been identified as an important risk factor for insulin resistance and the metabolic syndrome. In a recent study in patients with SDB and T2DM it was shown that CPAP therapy can lead to improvements in postprandial glucose levels and in glycosylated hemoglobin levels (HbA1c). In children, there are only 3 studies that have examined the relations between SDB, obesity and the metabolic syndrome. In order to further understand the relative contribution of SDB to the development of impaired glucose homeostasis and metabolic abnormalities we aim to investigate the prevalence and severity of SDB in children with T2DM compared to obese children without T2DM. The investigators hypothesize that SDB will be more prevalent and more severe among obese children with T2DM compared with the general obese pediatric population.
Interventions
None listed
Sponsors
Schneider Children's Hospital
Tel-Aviv Sourasky Medical Center
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
6 Years to 20 Years
Healthy volunteers
Yes
Inclusion criteria
* diagnosed with T2DM * obese
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigate the prevalence and severity of SDB among children with T2DM compared to its prevalence in non-diabetic obese children. | In 6 months |
| To measure markers of inflammation and oxidative stress known to be associated with cardiovascular morbidity in children with T2DM and SDB compared to non-diabetic obese children. | In 6 months |
| To examine changes in metabolic measures and markers of inflammation and oxidative stress in response to treatment for SDB (adenotonsillectomy) in children with T2DM compared to obese children without T2DM. | In 6 months |
Countries
Israel
Contacts
Primary ContactRiva Tauman, Dr.
Outcome results
None listed